demand for Diabetes Drugs are on the rise, but the reasons for their demand are being questioned.
The drug semaglutide was originally marketed under the name Ozempic to manage type 2 diabetes, but last year was approved by the FDA for weight loss under the name Wegovy.
But now the drug company Novo Nordisk is struggling to meet demand, which doctors say is causing problems for people with type 2 diabetes.
RELATED: National Diabetes Awareness Month: Know the Signs and Symptoms
“Our diabetics struggle to get drugs to control their blood sugar levels, so they have to replace them with other drugs to increase their insulin needs. I’m gaining weight back, and I’m actually gaining weight. obesity should be treated.
According to the CDC, more than 37 million Americans have diabetes, 90% to 95% of whom have type 2 diabetes.
